Navigation Links
MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
Date:4/22/2013

KENNESAW, Ga., April 22, 2013 /PRNewswire/ -- MiMedx Group, Inc. (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its common stock has been approved for listing on The NASDAQ Capital Market under the ticker symbol "MDXG."  Trading on NASDAQ is expected to commence on Thursday, April 25, 2013. Until such date, the Company's common stock will continue to be traded on OTC.BB under its current ticker symbol "MDXG".

"Listing on the NASDAQ exchange is an integral part of our plan to broaden and strengthen our shareholder base," said Parker H. "Pete" Petit, MiMedx Chairman and CEO.  "We expect the NASDAQ listing will increase the visibility of our stock, provide greater access to our stock and attract a broader range of investors to our stock, each of which is an essential element of our overall strategy to build shareholder value."

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary Purion® Process, to produce a safe, effective and minimally manipulated
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
2. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
3. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
4. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
5. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
6. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
7. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
8. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
9. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
10. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
11. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... August 19, 2014 Robin Williams’ passing ... can take on an individual. Symptoms range from ... expression, problems swallowing and severe depression. Parkinson’s disease ... off of dopamine producing neurons of the brain. ... disease that slowly and progressively gets worse, they look ...
(Date:8/19/2014)... In November 2012, the European Union (EU) mandated use of ... new PSUR – responding to the increasing need to understand ... Adopted in many regions, the main objectives of the PBRER ... critical analysis of new or emerging information on the risks ... of the potential benefits of a drug; and , ...
(Date:8/18/2014)... Dallas, Texas (PRWEB) August 19, 2014 ... China Linalool Industry” is a professional and in-depth ... report provides basic Linalool information, including its ... well as industry overview. This research covers the ... well as global industry analysis covering macroeconomic environment ...
(Date:8/18/2014)... Aug. 18, 2014   Sterne, Kessler, Goldstein & ... Washington, DC , announced today that ... Review (IPR) with the U.S. Patent and Trademark ... of BioReference Laboratories, Inc. (Nasdaq: BRLI).  These IPR petitions ... by Myriad Genetics, Inc. These patents have been asserted ...
Breaking Biology Technology:As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3
... NEW YORK, Sept. 7 Richard Gabriel, Chief,Executive ... DNAG),( http://www.dnaprint.com ) will be featured in an ... to take place on September 10 at 11,a.m. ... http://www.wallst.net by 8 p.m.,EDT on September 10. ...
... Inc. (Nasdaq: HGSI ) announced today that its ... New York will be webcast,and may be accessed at ... A member of Human Genome Sciences, senior management ... September 11, 2007 at 4:00 pm,Eastern Time. Investors ...
... Appeared More Effective Than rituximab ... in a ... GEN) announced today that ofatumumab (HuMax-CD20(R)) appeared more,effective at inducing ... in a pre-clinical study. The CD20,antibodies were incubated with tumor ...
Cached Biology Technology:WallSt.net (www.wallst.net) Announces Upcoming Interview With CEO of DNAPrint Genomics 2Genmab Announces Encouraging Preclinical Data for ofatumumab 2
(Date:8/19/2014)... August 19, 2014A new ovoid structure discovered in the ... contains a variety of minerals, and shows evidence of ... melting of the permafrost and mixing of surface and ... range of analytical studies to determine the origin of ... how this ovoid formed, point to the most likely ...
(Date:8/19/2014)... analyzed concentrations of African dust transported to South ... spring. These research findings offer new insight on ... of African dust, including the climate change-induced human ... increased African dust emissions in the coming decades., ... School of Marine and Atmospheric Science and colleagues ...
(Date:8/19/2014)... This news release is available in French . ... Stand: balancing the BENEFITS and RISKS of physical activity ... a stand on the promotion of childhood physical activity ... Applied Physiology, Nutrition, and Metabolism ( APNM ... of knowledge in the area of risk of physical ...
Breaking Biology News(10 mins):Life on Mars? Implications of a newly discovered mineral-rich structure 2Study of African dust transport to South America reveals air quality impacts 2Taking a stand: Balancing the BENEFITS and RISKS of physical activity in children 2Taking a stand: Balancing the BENEFITS and RISKS of physical activity in children 3
... may trigger the development of schizophrenia and other bipolar ... Faculty of Biological Sciences (UK) has shown that the ... these disorders by affecting the production of dopamine - ... aspects of movement, cognition and behaviour. Toxoplasmosis, which ...
... in genes which can result in changes in the ... associated with susceptibility to common diseases. In a new ... the Association for Psychological Science, psychologist Tina B. Lonsdorf ... and the University of Greifswald in Germany examined the ...
... fluoride (SO 2 F 2 ), a gas commonly used to ... that remains in the atmosphere about 36 years, six to 10 ... by Jens Mhle, an atmospheric chemist at Scripps Institution of Oceanography, ... the gas rose at a rate of 4 to 6 percent ...
Cached Biology News:Research supports toxoplasmosis link to schizophrenia 2The genetics of fear: Study suggests specific genetic variations contribute to anxiety disorders 2Termite killer lingers as a potent greenhouse gas 2Termite killer lingers as a potent greenhouse gas 3
Normal human serum, single donor...
... Quality ISO 9001:2000 Certified ... All Precedures Validated, SOP's Training ... Process for All Procedures GLP Documentation Upon ... one stop shopping point for all your ...
Human IL-17D Affinity Purified Polyclonal Ab...
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
Biology Products: